ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Crankbait
|
166 |
50K |
3 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
166
|
50K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Crankbait
|
166 |
50K |
3 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
166
|
50K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Crankbait
|
166 |
50K |
3 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
166
|
50K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Crankbait
|
166 |
50K |
0 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
166
|
50K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive PDCO opinion and A$20m Placement
|
|
Crankbait
|
166 |
50K |
2 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
166
|
50K
|
2
|
|
ASX - By Stock
|
PER |
Re:
$36.8m raise
|
|
Crankbait
|
219 |
70K |
3 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
219
|
70K
|
3
|
|
ASX - By Stock
|
PER |
Re:
$36.8m raise
|
|
Crankbait
|
219 |
70K |
4 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
219
|
70K
|
4
|
|
ASX - By Stock
|
PER |
Re:
$36.8m raise
|
|
Crankbait
|
219 |
70K |
0 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
219
|
70K
|
0
|
|
ASX - By Stock
|
PER |
Re:
$36.8m raise
|
|
Crankbait
|
219 |
70K |
1 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
219
|
70K
|
1
|
|
ASX - By Stock
|
PER |
Re:
$36.8m raise
|
|
Crankbait
|
219 |
70K |
3 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
219
|
70K
|
3
|
|
ASX - By Stock
|
PER |
Re:
$36.8m raise
|
|
Crankbait
|
219 |
70K |
2 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
219
|
70K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Crankbait
|
143 |
50K |
0 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
143
|
50K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Crankbait
|
143 |
50K |
2 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
143
|
50K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Crankbait
|
143 |
50K |
3 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
143
|
50K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
Crankbait
|
1.0K |
364K |
3 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
1.0K
|
364K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive feedback received on Paediatric Investigation Plan
|
|
Crankbait
|
221 |
80K |
3 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
221
|
80K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive feedback received on Paediatric Investigation Plan
|
|
Crankbait
|
221 |
80K |
0 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
221
|
80K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive feedback received on Paediatric Investigation Plan
|
|
Crankbait
|
221 |
80K |
8 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
221
|
80K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Sarepta and Nasdaq
|
|
Crankbait
|
8 |
3.9K |
0 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
8
|
3.9K
|
0
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Crankbait
|
183 |
76K |
2 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
183
|
76K
|
2
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Crankbait
|
183 |
76K |
9 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
183
|
76K
|
9
|
|
ASX - By Stock
|
PER |
Re:
US deal for ATL1102
|
|
Crankbait
|
202 |
74K |
0 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
202
|
74K
|
0
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Crankbait
|
183 |
76K |
1 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
183
|
76K
|
1
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Crankbait
|
183 |
76K |
1 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
183
|
76K
|
1
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Crankbait
|
183 |
76K |
5 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
183
|
76K
|
5
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Crankbait
|
183 |
76K |
0 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
183
|
76K
|
0
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Crankbait
|
183 |
76K |
4 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
183
|
76K
|
4
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Crankbait
|
183 |
76K |
0 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
183
|
76K
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
0 |
08/04/21 |
08/04/21 |
Charts
|
5.9K
|
2.2M
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
4 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.2M
|
4
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
0 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.2M
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
1 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.2M
|
1
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
0 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.2M
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
1 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.2M
|
1
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
0 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.2M
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
0 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.2M
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
1 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.2M
|
1
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
3 |
07/04/21 |
07/04/21 |
Charts
|
5.9K
|
2.2M
|
3
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Crankbait
|
183 |
76K |
8 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
183
|
76K
|
8
|
|
ASX - By Stock
|
PER |
Re:
ANP presenting now
|
|
Crankbait
|
183 |
76K |
18 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
183
|
76K
|
18
|
|
ASX - By Stock
|
PER |
Re:
US deal for ATL1102
|
|
Crankbait
|
202 |
74K |
3 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
202
|
74K
|
3
|
|
ASX - By Stock
|
PER |
Re:
US deal for ATL1102
|
|
Crankbait
|
202 |
74K |
6 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
202
|
74K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics appoints new Non-Executive Director
|
|
Crankbait
|
37 |
13K |
22 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
37
|
13K
|
22
|
|
ASX - By Stock
|
PER |
Re:
Ann: Antisense Therapeutics appoints new Non-Executive Director
|
|
Crankbait
|
37 |
13K |
12 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
37
|
13K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: FDA Rare Disease Day 2021
|
|
Crankbait
|
31 |
13K |
6 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
31
|
13K
|
6
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
0 |
15/03/21 |
15/03/21 |
Charts
|
5.9K
|
2.2M
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
3 |
11/03/21 |
11/03/21 |
Charts
|
5.9K
|
2.2M
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 DMD Paediatric Investigation Plan submitted to EMA
|
|
Crankbait
|
47 |
15K |
7 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
47
|
15K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 DMD Paediatric Investigation Plan submitted to EMA
|
|
Crankbait
|
47 |
15K |
3 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
47
|
15K
|
3
|
|
Charts
|
PER |
Re:
Chart
|
|
Crankbait
|
5.9K |
2.2M |
5 |
24/02/21 |
24/02/21 |
Charts
|
5.9K
|
2.2M
|
5
|
|